Medicine Long Used for Respiratory Ills Seen to Help Parkinson’s Patients in Small Trial

Medicine Long Used for Respiratory Ills Seen to Help Parkinson’s Patients in Small Trial
A medicine approved in the late 1970s to clear the respiratory tract and thin mucus can also cross the blood-brain barrier and possibly protect cells there from the damage seen in Parkinson’s disease, a small Phase 2 clinical trial has found. The study detailing these results, “Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations – ... read more
Source: Parkinson’s News TodayPublished on 2020-01-21By Catarina Silva, MSc